| Global Pharmaceutical Biotech Market 2010-2025 | | | | • Epogen. |
| | | | | |
| The global pharmaceutical biotech market | | | | Comprehensive analysis of the global biopharma |
| continues to experience high growth, with | | | | market: |
| developers ranging from major pharmaceutical | | | | |
| companies to specialist pharmaceutical firms. | | | | Global Pharmaceutical Biotech Market 2010-2025 |
| Significant R&D efforts and innovative new | | | | critically examines that sector through a |
| treatments will lead to further expansion of the | | | | comprehensive review of information sources and |
| pharma biotech market. This new report – | | | | original analysis. The report provides detailed sales |
| Global Pharmaceutical Biotech Market 2010-2025 | | | | forecasts, market share analyses, discussions of |
| – explains why that market will expand, | | | | pipeline developments and analyses of commercial |
| revealing where the most exciting developments | | | | drivers and restraints, including a SWOT analysis. |
| will lie. ( ) | | | | There are over 100 tables and figures included. |
| | | | | The result is a comprehensive market- and |
| This report examines markets for the following | | | | industry-centred study, with detailed analyses to |
| therapy classes: | | | | benefit your work. |
| | | | | |
| • Oncology | | | | Why you should buy Global Pharmaceutical |
| • Insulins | | | | Biotech Market 2010-2025? |
| • Immunosuppressive agents | | | | |
| • Autoimmune agents | | | | In this report you will receive the following |
| • Erythropoietin products | | | | benefits in particular: |
| • Immunostimulating agents | | | | |
| • Interferons | | | | • You will assess the current market for |
| • Pure vaccines | | | | pharma biotech products |
| • Blood coagulation factors | | | | • You will review the overall pharma biotech |
| • Growth hormones. | | | | market, including a global sales forecast for 2010 |
| | | | | to 2025 |
| Which therapy classes will lead the pharma | | | | • You will receive sales forecasts for the ten |
| biotech market in future? Where will the best | | | | leading biotech therapy classes from 2010 to |
| commercial opportunities lie from 2010 onwards? | | | | 2025, with detailed discussions |
| What are the most-crucial drivers and restraints in | | | | • You will receive sales forecasts for the |
| this increasingly-important market? This report will | | | | leading products in this market from 2010 to |
| provide you with the information that you need | | | | 2025, with detailed discussions of market potential |
| to understand current trends and future directions | | | | and competition |
| in the global biopharma sector, seeing how it will | | | | • You will receive sales forecasts for leading |
| further bolster the global pharma industry and | | | | geographical markets from 2010 to 2025, with |
| market. In particular, we discuss prospects for | | | | informed discussion |
| the following products: | | | | • You will examine commercial drivers and |
| | | | | restraints in depth, exploring their significance |
| • Enbrel | | | | • You will discover the most-exciting pipeline |
| • Remicade | | | | developments in the sector, across a range of |
| • Avastin | | | | therapy classes. |
| • Humira | | | | • Market growth, novel technologies and |
| • MabThera | | | | expansion into new therapeutic areas - our latest |
| • Herceptin | | | | report examines the significant technological and |
| • Lantus | | | | commercial opportunities in the global biopharma |
| • Neulasta | | | | market. |
| • Glivec | | | | |